Cargando…

Cyclic RGD-Functionalized pH/ROS Dual-Responsive Nanoparticle for Targeted Breast Cancer Therapy

Breast cancer is the most common malignant tumor in women and is a big challenge to clinical treatment due to the high morbidity and mortality. The pH/ROS dual-responsive nanoplatforms may be an effective way to significantly improve the therapeutic efficacy of breast cancer. Herein, we report a doc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Pu, Wang, Xiaowen, Wang, Qianmei, Dai, Qing, Peng, Yu, Yuan, Qian, Mou, Nan, Lv, Shan, Weng, Bangbi, Wang, Yu, Sun, Fengjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386338/ https://www.ncbi.nlm.nih.gov/pubmed/37514014 http://dx.doi.org/10.3390/pharmaceutics15071827

Ejemplares similares

Docetaxel-loaded pH/ROS dual-responsive nanoparticles with self-supplied ROS for inhibiting metastasis and enhancing immunotherapy of breast cancer
por: Wang, Yu, et al.
Publicado: (2023)

Folic acid-modified ROS-responsive nanoparticles encapsulating luteolin for targeted breast cancer treatment
por: Wang, Yu, et al.
Publicado: (2021)

Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma
por: Sun, Fengjun, et al.
Publicado: (2021)

Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging
por: Shi, Jiyun, et al.
Publicado: (2016)

The expression and significance of efferocytosis and immune checkpoint related molecules in pancancer samples and the correlation of their expression with anticancer drug sensitivity
por: Cheng, Lin, et al.
Publicado: (2022)

Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy
por: Ji, De, et al.
Publicado: (2020)

pH/Redox Dual-Responsive Drug Delivery System with on-Demand RGD Exposure for Photochemotherapy of Tumors
por: Li, Yaning, et al.
Publicado: (2022)

Targeted delivery of antibiotics to the infected pulmonary tissues using ROS-responsive nanoparticles
por: Wang, Yu, et al.
Publicado: (2019)

Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect
por: Liu, Hao, et al.
Publicado: (2022)

Comparison of cryptococcal meningitis in HIV-negative patients with and without lung infections
por: Yang, Ming, et al.
Publicado: (2020)

Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles
por: Chu, Yongchao, et al.
Publicado: (2017)

Dynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe
por: Zhu, Lei, et al.
Publicado: (2012)

Targeted Delivery of FLT-Morpholino Using Cyclic RGD Peptide
por: Uehara, Hironori, et al.
Publicado: (2017)

Cyclic RGD functionalized PLGA nanoparticles loaded with noncovalent complex of indocyanine green with urokinase for synergistic thrombolysis
por: Zhang, Sha, et al.
Publicado: (2022)

Cyclic RGD-conjugated Pluronic(®) blending system for active, targeted drug delivery
por: Lim, Chaemin, et al.
Publicado: (2018)

Dual Effect of Chemo-PDT with Tumor Targeting Nanoparticles Containing iRGD Peptide
por: Kim, Gye Lim, et al.
Publicado: (2023)

Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT
por: Zhou, Yang, et al.
Publicado: (2011)

Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells
por: Hada, Tomoya, et al.
Publicado: (2015)

Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide
por: Zhang, Qianyu, et al.
Publicado: (2016)

Targeted therapy for glioma using cyclic RGD-entrapped polyionic complex nanomicelles
por: Liu, Xiaoying, et al.
Publicado: (2012)

ROS-Responsive and pH-Sensitive Aminothiols Dual-Prodrug for Radiation Enteritis
por: Chen, Yuanfang, et al.
Publicado: (2022)

Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
por: Lin, Liteng, et al.
Publicado: (2020)

Density-tunable conjugation of cyclic RGD ligands with polyion complex vesicles for the neovascular imaging of orthotopic glioblastomas
por: Kawamura, Wataru, et al.
Publicado: (2015)

iRGD Peptide-Mediated Liposomal Nanoparticles with Photoacoustic/Ultrasound Dual-Modality Imaging for Precision Theranostics Against Hepatocellular Carcinoma
por: Li, Huipu, et al.
Publicado: (2021)

Hyaluronidase and pH Dual-Responsive Nanoparticles for Targeted Breast Cancer Stem Cells
por: Li, Weinan, et al.
Publicado: (2021)

RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy
por: Long, Qifang, et al.
Publicado: (2020)

New opportunities for RGD-engineered metal nanoparticles in cancer
por: Qin, Wei, et al.
Publicado: (2023)

RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy
por: Xu, Zichen, et al.
Publicado: (2023)

The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis
por: Zhang, Jin
Publicado: (2021)

Dual (pH- and ROS-) Responsive Antibacterial MXene-Based Nanocarrier for Drug Delivery
por: Zhang, Wei-Jin, et al.
Publicado: (2022)

Novel Bifunctional Cyclic Chelator for (89)Zr Labeling–Radiolabeling and Targeting Properties of RGD Conjugates
por: Zhai, Chuangyan, et al.
Publicado: (2015)

RGD Peptide-Conjugated Selenium Nanocomposite Inhibits Human Glioma Growth by Triggering Mitochondrial Dysfunction and ROS-Dependent MAPKs Activation
por: Liu, Wenjian, et al.
Publicado: (2021)

A folate/RGD‐dual‐functionalized mesoporous silica nanoparticles targeting GABA‐p38 MAPK‐MRTFs/SRF signaling pathway in rheumatoid arthritis
por: Deng, Xinqi, et al.
Publicado: (2021)

Dual-Mode Contrast Agents with RGD-Modified Polymer for Tumour-Targeted US/NIRF Imaging
por: Nie, Zhenhui, et al.
Publicado: (2020)

A novel dendrimer-based complex co-modified with cyclic RGD hexapeptide and penetratin for noninvasive targeting and penetration of the ocular posterior segment
por: Yang, Xiucheng, et al.
Publicado: (2019)

Retracted: The Application of Targeted Nanodrugs with Dual Responsiveness of PH and Ros in Preventing and Treating Vascular Restenosis
por: Healthcare Engineering, Journal of
Publicado: (2023)

pH-responsive delivery vehicle based on RGD-modified polydopamine-paclitaxel-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for targeted therapy in hepatocellular carcinoma
por: Wu, Mingfang, et al.
Publicado: (2021)

Evaluation of (111)In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability
por: Shi, Jiyun, et al.
Publicado: (2011)

Initial in vitro and in vivo assessment of Au@DTDTPA-RGD nanoparticles for Gd-MRI and 68Ga-PET dual modality imaging
por: Tsoukalas, Charalmpos, et al.
Publicado: (2015)

Walnut Polyphenol Extract Protects against Malathion- and Chlorpyrifos-Induced Immunotoxicity by Modulating TLRx-NOX-ROS
por: Zhao, Yue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p41h5fl38gosq74k01or9rkbnl